NASDAQ:ADTX

ADiTx Therapeutics, Inc Earning Date

USA |NASDAQ |USD

ADTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 31, 2021 (est) Sep 30, 2021 - $-0.42 $-0.38
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 31, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Aditx Therapeutics, Inc's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

ADTX Earnings Date & History Chart

ADTX Earnings & Revenue Forecast

ADTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.56 $0.56 $0.56
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.22 $0.22 $0.22
Dec 2022 0 $0.00 $0.00 $0.00

ADTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.56 $0.56 $0.56
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.22 $0.22 $0.22
Dec 2022 0 / 0 $0.90 $0.90 $0.90

ADTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $5.50M $5.50M $5.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $11.00M $11.00M $11.00M
Dec 2022 1 $42.42M $42.42M $42.42M

ADTX Earnings Date & Revenue History

ADTX Earnings History

|
Show More
Show More

ADTX Revenue History

|
Show More
Show More

Aditx Therapeutics, Inc Next Earnings Date & Report

ADTX Aug 2021 (FQ) Earnings Date & Report Preview

ADTX's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.

Aditx Therapeutics, Inc Previous Earnings Dates & Reports

ADTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Aditx Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

ADTX's earnings per share (EPS) was $-0.42, missing the consensus analysts forecast of $-0.05 by -740.00%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -0.99%, and lower than the same period a year before (Jun 2020) by 13.85%.

Revenues were $0.00.

The company reported a net income of $-6.18M.

Free cash flow for the quarter was $-5.24M , compared to $-4.54M last quarter and $-154.67K a year before.

ADTX ended the quarter with $8.61M in total debt, an increase of 51.97% compared to the previous quarter, and an increase of 923.83% compared to the same quarter a year before.

ADTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Aditx Therapeutics, Inc's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.

ADTX's earnings per share (EPS) was $-1.35, missing the consensus analysts forecast of $-0.73 by 84.34% , and higher than the previous year's EPS (Dec 2019) by -10.82%.

Revenues were $0.00.

The company reported a net income of $-9.15M.

Aditx Therapeutics, Inc reported a free cash flow of $-7.39M for its fiscal year, compared to $-464.35K a year ago.

The company ended the fiscal year with $1.84M in total debt, an increase of 1009.22% compared to the previous year.